Article Details
Retrieved on: 2021-04-05 20:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Maxwell Biosciences, a preclinical stage biotechnology company developing CLAROMER™ brand anti-infectives, today announced that the ...
Article found on: www.wfmz.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here